UC College of Pharmacy Dean Joins National Breast Cancer Research Panel
Cincinnati--Daniel Acosta, Jr., PhD, professor and dean of the
University of Cincinnati (UC) College of Pharmacy, has accepted an
invitation to serve as a member of the Integration Panel for the U.S.
Army's Breast Cancer Research Program (BCRP). He will serve a
three-year term on the 24-member panel which includes scientists,
consumer advocates, breast cancer survivors, and experts in basic,
transitional, clinical, psychosocial, and public health issues.
The diverse panel has a mix of races, genders, backgrounds, geographic
areas, and work environments.
In 1993, Congress appropriated $210 million to the Department of
Defense in response to a highly visible coalition of citizen's groups
seeking to increase breast cancer research efforts. The
Integration Panel is a vital component of the research program, acting
in an advisory capacity to the BCRP, and deciding on the distribution
of the research funds. The panel brings together experts from different
disciplines who have extensive knowledge and/or experience in breast
cancer-related issues. Since traditional chemotherapy or
radiation therapy treatments for breast cancer carry the risk of toxic
side effects, Acosta’s experience in toxicology should prove valuable
to the diverse panel. The panel will act to provide funds for
focused and coherent research, in an effort to eradicate breast cancer.
Acosta was named the dean of UC's College of Pharmacy in 1996, after
holding many prestigious positions at the University of Texas at
Austin. He is a member of many organizations including the
American Society for Pharmacology and Experimental Therapeutics, the
Society for In Vitro Biology, and the American Heart Association-Basic
Sciences Council. In addition, Acosta has been elected president
of the Society of Toxicology for the 2000-2001 term.